Sun Cen-Cen, Li Li, Jiang Zhi-Chen, Liu Zheng-Chuang, Wang Liang, Wang Hui-Ju
Basic Medical Experimental Teaching Center, Zhejiang University, Hangzhou 310030, Zhejiang, China.
Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China.
J Cancer. 2023 Jan 9;14(2):275-280. doi: 10.7150/jca.79171. eCollection 2023.
Pancreatic cancer (PaC) is a common malignant tumor of the digestive tract, with a 5-year survival rate of less than 5% and high mortality rate in the world. LncRNAs have been showed to possess multiple biological functions in growth, differentiation, and proliferation, which play an important role in different biological processes and diseases, especially in the development of tumors. LncRNA UCA1, which is firstly identified in human bladder cancer, has been showed to be a tumor promoter in pancreatic cancer. Recent researches have showed that UCA1 might promote pancreatic carcinogenesis and progression, and correlate with drug resistance. In this review, we address the biological function and regulatory mechanism of UCA1 in pancreatic cancer, which might give a new approach for clinical diagnosis and treatment.
胰腺癌(PaC)是一种常见的消化道恶性肿瘤,在全球范围内5年生存率低于5%,死亡率很高。长链非编码RNA(lncRNAs)已被证明在生长、分化和增殖过程中具有多种生物学功能,在不同的生物学过程和疾病中发挥重要作用,尤其是在肿瘤的发生发展中。LncRNA UCA1最早在人类膀胱癌中被发现,已被证明是胰腺癌中的一种肿瘤促进因子。最近的研究表明,UCA1可能促进胰腺癌的发生和进展,并与耐药性相关。在这篇综述中,我们阐述了UCA1在胰腺癌中的生物学功能和调控机制,这可能为临床诊断和治疗提供新的途径。